Physician profile
David J Clare
NPI 1891744975
$4,975.64
in general payments reported to CMS, 2019-2025
11 companies · $2,358 in 2025
The $2,358 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $201 · 2020: $1,617 · 2021: $64.35 · 2022: $311 · 2023: $88.37 · 2024: $336 · 2025: $2,358.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,676 · Education: $623 · Food and Beverage: $484.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,675.57 |
| Education | $623.31 |
| Food and Beverage | $483.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Conetic Solutions, INC. | $2,751.19 | 2020-2025 | |
| Arthrex, INC. | $1,255.78 | 2019-2025 | |
| Zimmer Biomet Holdings, INC. | $698.41 | 2024-2025 | Persona, Rosa |
| Stryker Corporation | $85.00 | 2022 | |
| Linvatec Corporation | $50.50 | 2022-2024 | Biobrace 23mm |
| Treace Medical Concepts, INC. | $34.51 | 2022 | |
| Heron Therapeutics, INC. | $30.00 | 2021 | |
| Boston Scientific Corporation | $21.86 | 2020 | |
| Depuy Synthes Sales INC. | $19.47 | 2021 | |
| Smith+Nephew, INC. | $15.14 | 2024 | Collagenase Santyl |
| Amgen INC. | $13.78 | 2023 | Evenity, Prolia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Clare listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.